Overview
Nuclivision operates in the nuclear medicine sector, positioning itself around future-proof technologies and approaches in this medical field.
Key people
In the news
- What if we could get more information from the PET scans we’re already performing? Only four days until our first webinar where Prof. Silvia Morbelli, MD discusses how better image quality could open the door to extracting more clinically relevant information from a single scan. Join us for a clinical deep-dive into how AI is transforming PET imaging in Alzheimer's disease management and explore together with Maarten Larmuseau how AI is transforming PET scanning today and what's on the horizon. 📅 Monday, September 22nd | 4:30
- Team Nuclivision is going to EANM 2026. And we want to make your visit count 🇦🇹 📅 October 17–21 📍 Booth 519 · Hall X5 At the booth you can: ✔️ See a live demo of Nuclarity on real clinical data ✔️ Measure the clinical and operational gains of AI in your department ✔️ Meet the team behind the product 🔬 NUCLARITY is also presented in two scientific talks this year covering pediatric PET imaging (together with the team from @Gustav Roussy) and Alzheimer imaging (together with Dr. Gloria Garelli (University of Turin/ Université de
- Amyloid PET isn’t just a “yes or no” scan. With anti-amyloid therapies changing the Alzheimer’s landscape, PET imaging is becoming increasingly important. But there’s still a gap: 👉 Most amyloid PET workflows tell us whether amyloid is present, but not necessarily how far neurodegeneration has progressed. That’s where dual-phase amyloid PET could change the conversation. One tracer injection. More information. Potentially greater insight into disease staging. The challenge? Short early-phase acquisitions are noisy. 🔬 Our
- Ziekenhuis Oost-Limburg (ZOL) was facing a challenge familiar to many departments: PET demand growing ~10% per year, waiting times of over a month, and a single scanner already running at capacity. NUCLARITY integrated easily into the existing infrastructure and deployment required minimal internal effort. But here's what changed: ✅ 20% increase in daily patient throughput without adding new equipment, ✅ 40% scan time reduction across [18F]-FDG and [18F]-PSMA with diagnostic image quality maintained ✅ Waiting times for PSMA PET went
- Something's cooking! 🎬 Last week we visited two of our Belgian customers CHU de Liège and CHIREC Hospital Group to shoot NUCLARITY's first product video. Real departments. Real workflows. Real feedback on NUCLARITY in action. Huge thanks to everyone who opened their doors, took the time to show us around, explained every detailed step along the way while caring for patients, and shared their unscripted thoughts on Nuclarity. ❤️
- A nuclear medicine department that doesn't optimise its operational flow is quietly falling behind and the cost of that is higher than most realise. We've put together a whitepaper on something we see in department after department: the cost of doing nothing. The demand continues to grow, waiting times become longer and time slots are fewer. And yet, the first instinct is still to look at hardware, though this takes time to procure, validate, and deploy. The pressure is already here. 👉 Link in first comment #NuclearMedicine
- We have some exciting news! Nuclivision is hosting its first-ever webinar. We're thrilled to welcome Prof Silvia Morbelli for a clinical deep-dive into how AI is transforming PET imaging in Alzheimer's disease management and she is joined by our CEO Maarten Larmuseau exploring further what impact AI can have on PET scanning today and what's on the horizon. If you work in nuclear medicine or neurology and want to understand where AI in PET imaging is headed, don't miss this one. Register here → https://lnkd.in/eNp355zK
- Two oral presentations at #EANM26, showing how NUCLARITY can help you do more with your existing scanner infrastructure 💪 ➡️ One on #amyloidPET: can shorter early-phase protocols still hold up diagnostically and help facilitating entry of anti-amyloid therapies in routine care? Presented by Dr. Gloria Garelli (University of Turin/Université de Genève) in the Neuroimaging Committee session ➡️ One on #pediatricPET dosing: how far can you bring radiation down in pediatric imaging and still trust what you see? Presented together
Alumni
Maarten LarmuseauSenior Data Scientist
Related profiles
Something wrong or missing? Send an update. Fixed within 24 hours.